News/ News/ News/ Oncology/ Sales and Marketing Novartis bags FDA okay for BRAF-positive tumour combination Phil Taylor BRAF, Mekinist, Novartis, novel targeted cancer treatments, Oncology, Tabrecta, Tafinlar 0 Comment Novartis’ two-drug regimen of Tafinlar and Mekinist has been approved by the FDA as the first therapy for Share X Novartis bags FDA okay for BRAF-positive tumour combination https://pharmaphorum.com/news/novartis-bags-fda-okay-for-braf-positive-tumour-combination/